$40.00
DSIP (delta sleep-inducing peptide, INN emideltide) is a nonapeptide first isolated in the 1970s from the cerebral venous blood of sleeping rabbits. It is studied in animal models of sleep electroencephalography, circadian timing and the hypothalamic-pituitary-adrenal (HPA) axis.
DSIP is a nonapeptide, a chain of nine amino acids, described in the scientific literature since the 1970s. Its International Nonproprietary Name is emideltide. The compound takes its name from the experiments in which it was isolated: infusion into rabbits was reported to increase delta-wave activity on the electroencephalogram. It is not an approved medicine in Canada or the United States, and the material supplied here is a research chemical.
Work on DSIP spans sleep electrophysiology, neuroendocrinology and stress physiology, and is mostly in rodents and rabbits. Findings across that literature are inconsistent, and the peptide has no established receptor. It is used as a research tool rather than as a compound with a settled mechanism.
Technical Specifications
Research Context
Areas that have been examined in the published literature include:
These are observations in laboratory models and should not be read as describing effects in a person or an animal outside a controlled study.
Storage and Handling
Testing and Quality Control
Every batch of DSIP is released against the following checks:
1. HPLC (high-performance liquid chromatography): to confirm a purity profile of ≥99.0%.
2. MS (mass spectrometry): to confirm the molecular weight and identity of the peptide.
3. Visual inspection: to confirm the consistency and integrity of the lyophilized cake.
For laboratory research use only. Not for human or veterinary use.
Further reading